CDKN2A and lung cancer: Inactivation of the p16Ink4a-pRb pathway and p14ARF-MDM2-p53 pathway by Bmi-1 deregulation has been clearly implicated in lymphomagenesis [9,10] and oncogenesis in nonsmall-cell lung cancer of human [11].